Dr. Andrea Fagiolini specializes in the pharmacological treatment and in the conduct of
treatment research protocols of mood and anxiety disorders. He is conducting research on
the pharmacological treatment of mood and anxiety disorders, the prevention and treatment
of medical comorbidities in individuals with bipolar disorders, and the importance of comorbid
sub-threshold psychiatric symptoms for the outcome of the primary psychiatric disorders.
Leadership Positions and Honors
Dr Fagiolini is Vice Chairman of the Division of Psychiatry, Dept of Neuroscience,
University of Siena
Fagiolini A, Buysse DJ, Frank E, Houck PR, Luther JF, Kupfer DJ: Tolerability of a combined
treatment with lithium and paroxetine in bipolar depressed patients. J Clin Psychopharmacol
Fagiolini A, Frank E, Houck PR, Mallinger AG, Swartz HA, Buysse DJ, Ombao H, Kupfer DJ:
Prevalence of obesity and weight change during treatment in patients with bipolar I disorder.
J Clin Psychiatry 63:528-533, 2002.
Fagiolini A, Kupfer DJ, Houck PR, Novick D, Frank E: Obesity as a correlate of outcome in
patients with bipolar I disorder. Am J Psychiatry 160:112-117, 2003.
Fagiolini A, Frank E, Scott JA, Turkin S, Kupfer DJ. Metabolic syndrome in bipolar disorder:
Findings from the Bipolar Disorder Center for Pennsylvanians. Bipolar Disorders
7: 424-430, 2005
|Revised 1/12/2009 la/tc|